Literature DB >> 15114308

Inter- and intra-observer variability in the measurement of length at endoscopy: Implications for the measurement of Barrett's esophagus.

Nalini M Guda1, Susan Partington, Nimish Vakil.   

Abstract

BACKGROUND: Endoscopic measurements are frequently used to determine the length of Barrett's epithelium. Decreases in measured length also are used to assess response to pharmacotherapy. The aim of this study was to determine the accuracy of the endoscopic measurement of length under standardized conditions.
METHODS: A life-size model of the esophagus was built by using an opaque polyvinyl tube. Transparent plastic inserts designed to resemble Barrett's epithelium were created. Ten different insert lengths were randomly studied. Trained endoscopists and fellows in training blinded to the lengths of the inserts performed measurements twice in random order.
RESULTS: A total of 240 measurements were made by 12 endoscopists. The mean difference (1 standard deviation) between the measured and correct length was 1.10 (1.7) cm. Overestimation of the length occurred in 47% and underestimation in 37%. The kappa statistic for the first and second measurement (within 0.5 cm) performed by the same individual (intra-observer) was 0.40, suggesting only fair agreement. There was considerable variability between endoscopists.
CONCLUSIONS: Accurate measurement of length at endoscopy is difficult even under ideal conditions. Intra-observer agreement is fair, but results obtained by different endoscopists are widely divergent. Small improvements in the length of Barrett's epithelium observed in some clinical trials could be because of chance instead of therapeutic effect.

Mesh:

Year:  2004        PMID: 15114308     DOI: 10.1016/s0016-5107(04)00182-8

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  15 in total

Review 1.  Critical appraisal of guidelines for screening and surveillance of Barrett's esophagus.

Authors:  Spyridon Michopoulos
Journal:  Ann Transl Med       Date:  2018-07

2.  IMportance of an Irregular Z Line: Is Barrett's in the Eye of the Beholder?

Authors:  Swathi Eluri; Nicholas J Shaheen
Journal:  Dig Dis Sci       Date:  2018-06       Impact factor: 3.199

3.  Predicting regression of Barrett's esophagus: results from a retrospective cohort of 1342 patients.

Authors:  Craig S Brown; Brittany Lapin; Chi Wang; Jay L Goldstein; John G Linn; Woody Denham; Stephen P Haggerty; Mark S Talamonti; John A Howington; Joann Carbray; Michael B Ujiki
Journal:  Surg Endosc       Date:  2014-05-02       Impact factor: 4.584

4.  Gastroesophageal flap valve status distinguishes clinical phenotypes of large hiatal hernia.

Authors:  Haruka Kaneyama; Mitsuru Kaise; Hiroshi Arakawa; Yoshinori Arai; Keisuke Kanazawa; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

5.  Gastroesophageal Reflux Disease, Esophagitis, and Barrett's Esophagus 3 to 4 Years Post Sleeve Gastrectomy.

Authors:  Samer Elkassem
Journal:  Obes Surg       Date:  2021-10-02       Impact factor: 4.129

6.  Barrett's esophagus: where do we stand?

Authors:  Majid A Al Madi
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

7.  Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma.

Authors:  Nour Hamade; Sreekar Vennelaganti; Sravanthi Parasa; Prashanth Vennalaganti; Srinivas Gaddam; Manon C W Spaander; Sophie H van Olphen; Prashanthi N Thota; Kevin F Kennedy; Marco J Bruno; John J Vargo; Sharad Mathur; Brooks D Cash; Richard Sampliner; Neil Gupta; Gary W Falk; Ajay Bansal; Patrick E Young; David A Lieberman; Prateek Sharma
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-08       Impact factor: 11.382

8.  Endoscopically defined gastroesophageal junction coincides with the anatomical gastroesophageal junction.

Authors:  Bengt Wallner
Journal:  Surg Endosc       Date:  2008-12-06       Impact factor: 4.584

9.  Length of Barrett's esophagus in the presence of low-grade dysplasia, high-grade dysplasia, and adenocarcinoma.

Authors:  Jenifer Barrie; Fady Yanni; Mohamed Sherif; Asha K Dube; Anand P Tamhankar
Journal:  Surg Endosc       Date:  2020-09-02       Impact factor: 4.584

10.  Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea.

Authors:  Hyun Jin Jo; Hye Seung Lee; Nayoung Kim; Ryoung Hee Nam; Hyun Chang; Min Soo Kim; Sung Eun Kim; Jane C Oh; Dong Ho Lee; Hyun Chae Jung
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.